The collagen matrix in corneal pathology, and the effect of new therapies for loss of transparency and refractive status
The collagen matrix in corneal pathology, and the effect of new therapies for loss of transparency and refractive status
批准号:
G0600755/1
负责人:
Keith Meek
金额:
$173.23万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The cornea is the transparent window at the front of the eye through which we see the coloured iris and black central pupil. It is made up mostly of a protein called collagen and forms part of the tough outer shell of the eye. Most of the outer shell is opaque and white in colour, but the cornea has evolved to transmit light. Evidently, the transparency of the cornea is absolutely essential for vision, and it is believed that the reason why the cornea, unlike all other collagen-containing tissues in the body, is transparent, is because of the special size and arrangement of the collagen and the special properties of the interspersed cells. One purpose of our proposed investigation is to discover precisely how the arrangement of the collagen and the properties of the cells allow the cornea to be transparent. We will then examine how certain treatments act to restore transparency where it has been lost. In addition to allowing light into the eye, the cornea is also curved in a special way to help focus the incoming light on the retina. Again, it is believed that aspects of the collagen organisation might influence this curvature and be important for corneal astigmatism and the recovery of good vision after corneal surgery (including new refractive surgeries such as LASIK). The research is to be carried out using a range of techniques, including synchrotron x-ray technology and several high powered microscopical methods. It will be carried out by a team of Biophysicists in Cardiff, but will involve a number of scientists and clinicians from around the world.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The ultrastructural basis of corneal dysfunction and the development and optimization of novel therapeutic strategies
-
批准号:MR/K000837/1
-
项目类别:Research Grant
-
资助金额:$223.59万
-
财政年份:2012
-
负责人:Keith Meek
-
依托单位:
The ostracod carapace window as a biomimetic basis for development of a novel eye shield.
-
批准号:BB/J019879/1
-
项目类别:Research Grant
-
资助金额:$14.28万
-
财政年份:2012
-
负责人:Keith Meek
-
依托单位:
国内基金
海外基金
登录
查看更多内容
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
基于Matrix2000加速器的个性小数据在线挖掘
-
批准号:2020JJ4669
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:甘新标
-
依托单位:
细胞重编程过程中的细胞通讯和命运决定机制研究
-
批准号:U20A2013
-
项目类别:联合基金项目
-
资助金额:253.0万元
-
批准年份:2020
-
负责人:王涛
-
依托单位:
氧化应激诱导血管发生微环境中Fibronectin组装异常的机制研究
-
批准号:31801174
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2018
-
负责人:乔梁峻
-
依托单位:
幽门螺杆菌感染促进肿瘤相关成纤维细胞与胃癌细胞的互作及机制研究
-
批准号:31760328
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2017
-
负责人:周建奖
-
依托单位:
基质刚度介导YAP/TAZ信号调控对硬皮病成纤维细胞增殖活化的靶向基质效应研究
-
批准号:81760301
-
项目类别:地区科学基金项目
-
资助金额:32.0万元
-
批准年份:2017
-
负责人:马云青
-
依托单位:
抑制肿瘤转移的新靶点: iPLA2在整合素和基质金属蛋白酶再循环中的新颖作用
-
批准号:31671450
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2016
-
负责人:CHANG YONG CHUNG
-
依托单位:
VEGFR-1/Src/miR-21/MMP-9信号轴调控肝细胞癌侵袭转移的机制研究
-
批准号:81660487
-
项目类别:地区科学基金项目
-
资助金额:37.0万元
-
批准年份:2016
-
负责人:时军
-
依托单位:
树突状细胞迁移的分子机制及其在RA发病机制中的作用
-
批准号:81471613
-
项目类别:面上项目
-
资助金额:75.0万元
-
批准年份:2014
-
负责人:孙尔维
-
依托单位:
毫米波封装系统中高效、高精度的滤波器建模方法研究
-
批准号:61101047
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:王建朋
-
依托单位: